https://www.clinicaltrialsarena.com/news/imbrium-ind-sunobinop-trial/
Imbrium files IND application for sunobinop trial
Aug 6, 2024 - Imbrium Therapeutics has announced the IND submission to the US FDA for a Phase II trial of sunobinop to treat alcohol use disorder.
ind applicationimbriumfilessunobinoptrial